开云app官网登录入口网页版-官方正版

#SpA#

99篇内容 | 1993人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1989471, encodeId=9e4c19894e1a5, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=ARD：托珠单抗治疗新发风湿性多肌痛(PMR-SPARE)：一项2/3期随机对照试验, objectType=article, longId=731063, objectId=3052e310638a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3052e310638a, replyNumber=0, likeNumber=126, createdTime=2022-08-23, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3052e310638a, moduleTitle=ARD：托珠单抗治疗新发风湿性多肌痛(PMR-SPARE)：一项2/3期随机对照试验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3052e310638a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989470, encodeId=b55f19894e0ba, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=J Clin Oncol：Spartalizumab 联合达拉非尼和曲美替尼治疗黑色素瘤的疗效, objectType=article, longId=729628, objectId=bf1ee296289d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf1ee296289d, replyNumber=0, likeNumber=95, createdTime=2022-10-15, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf1ee296289d, moduleTitle=J Clin Oncol：Spartalizumab 联合达拉非尼和曲美替尼治疗黑色素瘤的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bf1ee296289d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989468, encodeId=353f1989468ad, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=新型取栓技术（SPACEMAN）的技术考虑和应用场景：一项前瞻性研究, objectType=article, longId=300238, objectId=50113002384a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50113002384a, replyNumber=0, likeNumber=87, createdTime=2023-02-13, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50113002384a, moduleTitle=新型取栓技术（SPACEMAN）的技术考虑和应用场景：一项前瞻性研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=50113002384a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989465, encodeId=4f3a19894655f, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Diabetes：COVID-19的老年肥胖糖尿病患者可能通过GRP78 (BIP/HSPA5)参与到脂肪组织中, objectType=article, longId=219565, objectId=dbdc219565c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbdc219565c4, replyNumber=0, likeNumber=90, createdTime=2022-03-10, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbdc219565c4, moduleTitle=Diabetes：COVID-19的老年肥胖糖尿病患者可能通过GRP78 (BIP/HSPA5)参与到脂肪组织中, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=dbdc219565c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989469, encodeId=b21619894691f, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=ATVB：Caspase-8通过激活炎症因子的产生促进肺动脉高压, objectType=article, longId=723924, objectId=3d21e2392495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d21e2392495, replyNumber=0, likeNumber=78, createdTime=2022-07-13, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d21e2392495, moduleTitle=ATVB：Caspase-8通过激活炎症因子的产生促进肺动脉高压, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3d21e2392495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989466, encodeId=659519894661f, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=J Clin Oncol：III期临床研究评估PD-1抑制剂Spartalizumab 联合Dabrafenib（达拉非尼）+ Trametinib（曲美替尼）治疗BRAF V600突变不可切除或转移性黑色素瘤的疗效, objectType=article, longId=294057, objectId=20b829405e40, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20b829405e40, replyNumber=0, likeNumber=51, createdTime=2022-09-07, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20b829405e40, moduleTitle=J Clin Oncol：III期临床研究评估PD-1抑制剂Spartalizumab 联合Dabrafenib（达拉非尼）+ Trametinib（曲美替尼）治疗BRAF V600突变不可切除或转移性黑色素瘤的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=20b829405e40)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989463, encodeId=d19c198946393, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=数字疗法巨头诞生！心理健康巨头Headspace 和 Ginger 合并市值超30 亿美元, objectType=article, longId=216323, objectId=2b552163233a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b552163233a, replyNumber=0, likeNumber=74, createdTime=2021-12-11, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b552163233a, moduleTitle=数字疗法巨头诞生！心理健康巨头Headspace 和 Ginger 合并市值超30 亿美元, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2b552163233a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989467, encodeId=5235198946e4e, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Front Immunol：联合治疗通过抑制Caspase-1/Gasdermin D诱导狼疮性肾炎细胞焦亡的新作用, objectType=article, longId=294149, objectId=12f429414970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12f429414970, replyNumber=0, likeNumber=78, createdTime=2022-05-27, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12f429414970, moduleTitle=Front Immunol：联合治疗通过抑制Caspase-1/Gasdermin D诱导狼疮性肾炎细胞焦亡的新作用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=12f429414970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989462, encodeId=64891989462a8, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=J Clin Oncol：Pegaspargase和Calaspargase Pegol治疗儿童ALL的疗效和毒性, objectType=article, longId=214106, objectId=eb67214106de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb67214106de, replyNumber=0, likeNumber=66, createdTime=2021-11-24, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb67214106de, moduleTitle=J Clin Oncol：Pegaspargase和Calaspargase Pegol治疗儿童ALL的疗效和毒性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=eb67214106de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989460, encodeId=2adb1989460d1, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Nat Commun：CD318、TSPAN8和CD66c为胰腺癌CAR-T细胞疗法的候选靶标, objectType=article, longId=208290, objectId=058f2082904e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=058f2082904e, replyNumber=0, likeNumber=78, createdTime=2021-05-27, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=058f2082904e, moduleTitle=Nat Commun：CD318、TSPAN8和CD66c为胰腺癌CAR-T细胞疗法的候选靶标, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=058f2082904e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989464, encodeId=d47e19894649a, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Aspaveli (pegcetacoplan) 治疗阵发性夜间血红蛋白尿症 (PNH)，已获得欧盟CHMP积极意见, objectType=article, longId=218729, objectId=4cd6218e291b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cd6218e291b, replyNumber=0, likeNumber=66, createdTime=2022-02-25, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cd6218e291b, moduleTitle=Aspaveli (pegcetacoplan) 治疗阵发性夜间血红蛋白尿症 (PNH)，已获得欧盟CHMP积极意见, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4cd6218e291b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989461, encodeId=1d67198946131, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=SpaceX星舰SN15超预期平稳着陆，曹原石墨烯研究再获新突破 | 一周科技导读, objectType=article, longId=211092, objectId=2edc2110923e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2edc2110923e, replyNumber=0, likeNumber=74, createdTime=2021-09-04, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2edc2110923e, moduleTitle=SpaceX星舰SN15超预期平稳着陆，曹原石墨烯研究再获新突破 | 一周科技导读, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2edc2110923e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989458, encodeId=73f2198945896, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=SPATA：基因集驱动的空间转录组分析框架, objectType=article, longId=206865, objectId=c5f920686566, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5f920686566, replyNumber=0, likeNumber=73, createdTime=2021-02-20, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5f920686566, moduleTitle=SPATA：基因集驱动的空间转录组分析框架, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c5f920686566)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989455, encodeId=69ae19894552b, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Cell Death Differ：SPAP5的异常表达促进乳腺癌细胞的增殖, objectType=article, longId=203858, objectId=c7e6203858a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7e6203858a0, replyNumber=0, likeNumber=69, createdTime=2021-04-13, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7e6203858a0, moduleTitle=Cell Death Differ：SPAP5的异常表达促进乳腺癌细胞的增殖, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c7e6203858a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989457, encodeId=446c198945e75, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=百时美施贵宝血液病创新药Luspatercept上市申请获CDE优先审评, objectType=article, longId=206759, objectId=7050206e59ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7050206e59ba, replyNumber=0, likeNumber=75, createdTime=2021-08-09, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7050206e59ba, moduleTitle=百时美施贵宝血液病创新药Luspatercept上市申请获CDE优先审评, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7050206e59ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989453, encodeId=4a021989453f1, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=轻轻松松掌握文献知识图谱，发现科研创新思路——CiteSpace, objectType=article, longId=200626, objectId=b4b12006261d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4b12006261d, replyNumber=0, likeNumber=82, createdTime=2021-01-20, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4b12006261d, moduleTitle=轻轻松松掌握文献知识图谱，发现科研创新思路——CiteSpace, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b4b12006261d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989450, encodeId=27ee198945095, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Cell Host & Microbe：情绪牵肠道！脸上带smile，肠道做SPA！, objectType=article, longId=195681, objectId=ecee19568113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecee19568113, replyNumber=0, likeNumber=102, createdTime=2020-09-21, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecee19568113, moduleTitle=Cell Host & Microbe：情绪牵肠道！脸上带smile，肠道做SPA！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ecee19568113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989449, encodeId=207b19894497c, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Cell Death Diff：HSPA12A可作为LPS诱导性肝损伤的治疗靶点, objectType=article, longId=193627, objectId=519819362ec1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=519819362ec1, replyNumber=0, likeNumber=71, createdTime=2021-01-03, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=519819362ec1, moduleTitle=Cell Death Diff：HSPA12A可作为LPS诱导性肝损伤的治疗靶点, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=519819362ec1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989459, encodeId=1ba81989459dc, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Sparsentan治疗IgA肾病（IgAN），EMA已授予Sparsentan“孤儿药称号”, objectType=article, longId=207390, objectId=460c20e390d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=460c20e390d3, replyNumber=0, likeNumber=93, createdTime=2022-01-29, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=460c20e390d3, moduleTitle=Sparsentan治疗IgA肾病（IgAN），EMA已授予Sparsentan“孤儿药称号”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=460c20e390d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989454, encodeId=fa3e198945431, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Cell Death Dis：SPATS2调控细胞周期促进肝癌的发生发展, objectType=article, longId=202307, objectId=195120230ef9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=195120230ef9, replyNumber=0, likeNumber=93, createdTime=2021-08-06, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=195120230ef9, moduleTitle=Cell Death Dis：SPATS2调控细胞周期促进肝癌的发生发展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=195120230ef9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

SpA

2020-05-29

gostraight (审核中...)

前往app查看评论内容

#SpA#

ARD：托珠单抗治疗新发风湿性多肌痛(PMR-SPARE)：一项2/3期随机对照试验

2022-08-23

gostraight (审核中...)

前往app查看评论内容

#SpA#

J Clin Oncol：Spartalizumab 联合达拉非尼和曲美替尼治疗黑色素瘤的疗效

2022-10-15

gostraight (审核中...)

前往app查看评论内容

#SpA#

新型取栓技术（SPACEMAN）的技术考虑和应用场景：一项前瞻性研究

2023-02-13

gostraight (审核中...)

前往app查看评论内容

#SpA#

Diabetes：COVID-19的老年肥胖糖尿病患者可能通过GRP78 (BIP/HSPA5)参与到脂肪组织中

2022-03-10

gostraight (审核中...)

前往app查看评论内容

#SpA#

ATVB：Caspase-8通过激活炎症因子的产生促进肺动脉高压

2022-07-13

gostraight (审核中...)

前往app查看评论内容

#SpA#

J Clin Oncol：III期临床研究评估PD-1抑制剂Spartalizumab 联合Dabrafenib（达拉非尼）+ Trametinib（曲美替尼）治疗BRAF V600突变不可切除或转移性黑色素瘤的疗效

2022-09-07

gostraight (审核中...)

前往app查看评论内容

#SpA#

数字疗法巨头诞生！心理健康巨头Headspace 和 Ginger 合并市值超30 亿美元

2021-12-11

gostraight (审核中...)

前往app查看评论内容

#SpA#

Front Immunol：联合治疗通过抑制Caspase-1/Gasdermin D诱导狼疮性肾炎细胞焦亡的新作用

2022-05-27

gostraight (审核中...)

前往app查看评论内容

#SpA#

J Clin Oncol：Pegaspargase和Calaspargase Pegol治疗儿童ALL的疗效和毒性

2021-11-24

gostraight (审核中...)

前往app查看评论内容

#SpA#

Nat Commun：CD318、TSPAN8和CD66c为胰腺癌CAR-T细胞疗法的候选靶标

2021-05-27

gostraight (审核中...)

前往app查看评论内容

#SpA#

Aspaveli (pegcetacoplan) 治疗阵发性夜间血红蛋白尿症 (PNH)，已获得欧盟CHMP积极意见

2022-02-25

gostraight (审核中...)

前往app查看评论内容

#SpA#

SpaceX星舰SN15超预期平稳着陆，曹原石墨烯研究再获新突破 | 一周科技导读

2021-09-04

gostraight (审核中...)

前往app查看评论内容

#SpA#

SPATA：基因集驱动的空间转录组分析框架

2021-02-20

gostraight (审核中...)

前往app查看评论内容

#SpA#

Cell Death Differ：SPAP5的异常表达促进乳腺癌细胞的增殖

2021-04-13

gostraight (审核中...)

前往app查看评论内容

#SpA#

百时美施贵宝血液病创新药Luspatercept上市申请获CDE优先审评

2021-08-09

gostraight (审核中...)

前往app查看评论内容

#SpA#

轻轻松松掌握文献知识图谱，发现科研创新思路——CiteSpace

2021-01-20

gostraight (审核中...)

前往app查看评论内容

#SpA#

Cell Host & Microbe：情绪牵肠道！脸上带smile，肠道做SPA！

2020-09-21

gostraight (审核中...)

前往app查看评论内容

#SpA#

Cell Death Diff：HSPA12A可作为LPS诱导性肝损伤的治疗靶点

2021-01-03

gostraight (审核中...)

前往app查看评论内容

#SpA#

Sparsentan治疗IgA肾病（IgAN），EMA已授予Sparsentan“孤儿药称号”

2022-01-29

gostraight (审核中...)

前往app查看评论内容

#SpA#

Cell Death Dis：SPATS2调控细胞周期促进肝癌的发生发展

2021-08-06

科室
- - 订阅+
  - 更多科室
工具
服务